Revolution Medicines, Inc. is 22.1x more valuable than Monte Rosa Therapeutics, Inc. by market capitalization ($30.65 B vs $1.39 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GLUE | RVMD |
|---|---|---|
| Market cap | $1.39 B | $30.65 B |
| US-listed rank | #2397 | #454 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | -$38.60M | -$1.13B |
| SEC filings | 352 | 782 |
Revolution Medicines, Inc. is 22.1x more valuable than Monte Rosa Therapeutics, Inc. by market capitalization ($30.65 B vs $1.39 B).
Full pages: Monte Rosa Therapeutics, Inc. and Revolution Medicines, Inc., or browse the full rankings.